TotalMarketCap

Prime Medicine

PRMENasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$806.220 M

$4.45 -10.56%

Close of 6 Nov 2026

As of 6 Nov 2026, Prime Medicine (PRME) has a market capitalization of $806.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$4.63M

#3279 by revenue

Earnings

-$201.1M

Loss-making

Shares outstanding

181,376,856

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #48Monte Rosa TherapeuticsGLUE$872.8M
  2. #49MeiraGTxMGTX$818.2M
  3. #50Prime MedicinePRME$806.2M
  4. #51Cullinan TherapeuticsCGEM$704.0M
  5. #52Sana BiotechnologySANA$697.5M

What if Prime Medicine were worth as much as…

Open the what-if tool →

Gold $28.2T

$155,680.69

Per share 35,024× higher

Bitcoin $1.53T

$8,423.61

Per share 1,895× higher

Apple $5.02T

$27,653.93

Per share 6,221× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Prime Medicine are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.